MCRS1 sensitizes T cell-dependent immunotherapy by augmenting MHC-I expression in solid tumors.
Li X, Yi H, Jin Z, Jiang K, Xue K, Wang J, Qian Y, Xiang Q, Zhu S, Yan R, Yang Y, Sun S, Li K, Zhou Z, Yu W, Jiang N, Ding C, Lin X, Zhong J, Dong Y, Liu Y, Yu X.
Li X, et al. Among authors: xiang q.
J Exp Med. 2024 Dec 2;221(12):e20240959. doi: 10.1084/jem.20240959. Epub 2024 Nov 15.
J Exp Med. 2024.
PMID: 39545935